期刊文献+

原发性胆汁性肝硬化患者共刺激分子B7-H4的检测及临床意义 被引量:2

Expression of costimulating factor B7-H4 in patients with primary binary cirrhosis
原文传递
导出
摘要 目的探讨原发性胆汁性肝硬化(primary biliary cirrhosis,PBC)患者共刺激因子B7-H4的表达及其与疾病发病机制的关系。方法分别采用荧光实时定量PCR法(real-time PCR)、酶联免疫吸附试验(ELISA)及流式细胞术(FCM)检测65名PBC患者外周血单个核细胞(PBMC)B7-H4 mRNA表达水平、血清IL-2水平以及CD4^+、CD8^+T细胞亚群和T细胞表面B7-H4表达百分率,同时监测抗线粒体抗体(anti-mitochondrial antibody,AMA)及临床各项生化指标的关系。结果(1)PBC患者PBMC B7-H4 mRNA水平及T细胞表面B7-H4表达百分率显著低于非PBC肝硬化组及健康对照组(P〈0.01)。(2)活化72h后各实验组及对照组IL-2含量及CD4^+、CD8^+、CD4^+CD8^+T淋巴细胞表达水平均低于活化前,以非PBC肝硬化组与健康对照组降低显著(P〈0.05);PBC组IL-2含量及CD4^+、CD4^+CD8^+T淋巴细胞表达水平高于非PBC肝硬化组与健康对照组(P〈0.01)。(3)AMA-M2阳性患者血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、碱性磷酸酶(ALP)及γ-谷氨酰转肽酶(GGT)水平升高,其中ALP及GGT升高显著(P〈0.05);AMA—M2阳性患者与阴性患者T细胞表面B7-H4表达百分率差异无统计学意义(P〉0.05)。结论共刺激因子B7-H4对PBC患者体内T细胞活化增殖及细胞因子分泌的抑制作用减弱,为研究PBC的发生发展和阐明PBC的发病机制提供了试验资料。 Objective To study the relationship between the expression of costimulating factor BT- H4 in patients with primary biliary cirrhosis (PBC) and the pathogenesis of PBC. Methods The expression of B7-H4 mRNA on peripheral blood mononuclear cell (PBMC) of 65 patients with PBC was tested by realtime PCR. Serum levels of IL-2 were assayed by ELISA. CD4^ + , CD8^ + T lymphocytes expression level and B7-H4 expression rate before and after activation were measured by three-color flow cytometry (FCM). Resuits ( 1 ) Expression of B7-H4 mRNA and BT-H4 percentage in PBC group were significantly lower than that in none-PBC group and healthy controls ( P 〈 0.01 ) ; ( 2 ) After 72 h activation, the percentage of CD4^+ , CD8 ^+ , and CD4 ^+ CD8 ^+ T lymphocytes and serum levels of IL-2 decreased ( P 〈 0.05 ), and the percentage of CD4 ^+ , CD4 ^+ CD8 ^+ T lymphocytes and serum levels of IL-2 were significantly higher than that of none- PBC group and healthy controls (P 〈 0.01 ) ;( 3 ) Levels of alanine aminotransferase (ALT), aspartate aminotransferase( AST), alkaline phosphatase(ALP) and γ-glutamyl transpeptidase(GGT) of patients with posi- tive anti-mitochondrial antibody(AMA)-M2 rose. There was no significant difference of BT-H4 expressions on T cells between patients either with or without AMA-M2 antibody. Conclusion The costimulating factor BT-H4 can express on T lymphocytes which is activated by phytohemagglutinin(PHA) and plays a negative role on T cells responses.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2008年第9期851-855,共5页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助(30471617,30640084) 国家高技术研究发展技划(863计划)重大专项基金资助项目(2002AARTZ2011,2006AA02Z436)
关键词 原发性胆汁性肝硬化 外周血单个核细胞 共刺激因子 B7-H4 抗线粒体抗体 Primary biliary cirrhosis Peripheral blood mononuclear cells Costimulating factor B7-H4 Anti-mitochondrial antibody
  • 相关文献

参考文献4

二级参考文献37

  • 1Chuzouilleres O,Wendum D.serfaty L.et al.Primiry billary cirrhosis-autoimmune hepatitis overlap syndrome clinical features and response to therapy.Hepatology.1998.28:296-301. 被引量:1
  • 2Heathcote EJ.Management of primary biliary cirrhosis.The American association for the study of liver diseases practice guidelines.Hepatology,2000.31:1005-1013. 被引量:1
  • 3Alvarez F.Berg PA.Bianchi FB.et al.International Autoimmune Hepatitis Group Report:review of diagnosis of autoimmune bepatitis.J Hepatol.1999.31:929-938. 被引量:1
  • 4Czaja A.Carpenter HA.Validation of scoring system for diagnosis of autoimmunc hepatitis.Dig Dis Sci.1996.41:305-314. 被引量:1
  • 5蒋健 高月求.原发性胆汁性肝硬化的诊断和治疗[J].美国中华医药杂志,2001,7(2):16-18. 被引量:4
  • 6James OF;Bhopal R;Howel D.Primary biliary cir rho sis once rare,now common in the United Kingdom?[J],1999(2). 被引量:2
  • 7Metcalf J;James O.The geoepidemiology of primary biliary cirrhosis[J],1997. 被引量:1
  • 8Kaplan MM.Primary biliary cirrhosis[J],1996. 被引量:1
  • 9Poupon R;Chazouilleres O;Balkau B.Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis.UDCA-PBC Group[J],1999. 被引量:1
  • 10Mackay IR;Gershwin ME.The nature of autoimmune disease.m[J],1997. 被引量:1

共引文献44

同被引文献33

  • 1毛一香,张学光.B7-H4——B7家族的又一新成员[J].中国免疫学杂志,2005,21(5):395-397. 被引量:6
  • 2Yi-xiang MAO,Yong-Jing CHEN,Yan GE,Hong-bing MA,Jian-feng YU,Hong-ya WU,Yu-min HU,Qin WANG,Qin SHI,Xue-guang ZHANG.Recombinant human B7-H4 expressed in Escherichia coli inhibits T lym-phocyte proliferation and IL-2 secretion in vitro[J].Acta Pharmacologica Sinica,2006,27(6):741-746. 被引量:16
  • 3Carreno BM,Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses[J]. Annu Rev lmmunol,2002,20:29-53. 被引量:1
  • 4Carter LL, Carreno BM Cytotoxic T-lymphocyte antigen-4 and programmed death-l function as negative regulators of lymphocyte activation[J].lmmunol Res,2003,28(1):49-59. 被引量:1
  • 5Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity[J]. lmmunity,2003,18 (6): 849-861. 被引量:1
  • 6Choi IH, Zhu G, Siea GL, el al. Genomic organization and analysis of B7-H4, an immune inhibitory molecule of the B7 family[J]. J Immunol,2003,171 (9):4650-4654. 被引量:1
  • 7Salceda S,Tang T, Kmet M, et al.The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation[J]. Exp Cell Res,2005,306:128-141. 被引量:1
  • 8Zou W, Chen L.lnhibitory B7-family molecules in the tumour microenvironment[J]. Nat Rev lmmunol,2008, 8:467-477. 被引量:1
  • 9Prasad DV, Richards S, Mai XM, et al. B7s1, a novel B7 family member that negatively regulates T cell activation[J]. lmmunity,2003, 18(6):863-873. 被引量:1
  • 10Simon I, Zhuo S, Corral L, et al. B7-H4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer[J]. Cancer Res,2006,66(3):1570. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部